Publication Date
5-1-2022
Keywords
health, public policy
Volume
2022
Abstract
Insulin is a life-preserving medicine for individuals with type 1 diabetes. Insulin is especially inaccessible in the United States compared to other high-income nations due to patents and production monopolies, insufficient insurance coverage and other barriers to healthcare, and increased use of insulin analogs. As a result. individuals affected by this face a series of challenges, from turning to insulin rationing, and high rates of diabetic ketoacidosis. to a high mental toll. While this remains a complex issue. policy measures may be an effective way to make insulin more accessible for more Americans. Education on the need for better access to insulin is also an important practice to mitigate the issue. The complexities are vast, but the issue is crucial to address to help people with type 1 diabetes live prosperous lives.
Recommended Citation
Randall, Hannah
(2022)
"Lack of Access to Insulin among People with Type 1 Diabetes in the US,"
Ballard Brief: Vol. 2022:
Iss.
2, Article 3.
Available at:
https://scholarsarchive.byu.edu/ballardbrief/vol2022/iss2/3